MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents A Bolomsky, M Vogler, MC Köse, CA Heckman, G Ehx, H Ludwig, J Caers Journal of hematology & oncology 13, 1-19, 2020 | 121 | 2020 |
Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice G Ehx, J Somja, HJ Warnatz, C Ritacco, M Hannon, L Delens, G Fransolet, ... Frontiers in immunology 9, 1943, 2018 | 77 | 2018 |
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes G Ehx, JD Larouche, C Durette, JP Laverdure, L Hesnard, K Vincent, ... Immunity 54 (4), 737-752. e10, 2021 | 75 | 2021 |
Comparison of mesenchymal stromal cells from different origins for the treatment of graft-vs.-host-disease in a humanized mouse model C Grégoire, C Ritacco, M Hannon, L Seidel, L Delens, L Belle, S Dubois, ... Frontiers in immunology 10, 619, 2019 | 69 | 2019 |
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects G Ehx, G Fransolet, L De Leval, S D'Hondt, S Lucas, M Hannon, L Delens, ... Oncoimmunology 6 (5), e1314425, 2017 | 56 | 2017 |
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients L Canti, S Humblet-Baron, I Desombere, J Neumann, P Pannus, ... Journal of hematology & oncology 14, 1-12, 2021 | 51 | 2021 |
Widespread and tissue-specific expression of endogenous retroelements in human somatic tissues JD Larouche, A Trofimov, L Hesnard, G Ehx, Q Zhao, K Vincent, C Durette, ... Genome medicine 12, 1-16, 2020 | 47 | 2020 |
Discovery and characterization of actionable tumor antigens G Ehx, C Perreault Genome medicine 11 (1), 29, 2019 | 44 | 2019 |
Immune recovery after allogeneic hematopoietic stem cell transplantation following flu-TBI versus TLI-ATG conditioning M Hannon, Y Beguin, G Ehx, S Servais, L Seidel, C Graux, J Maertens, ... Clinical Cancer Research 21 (14), 3131-3139, 2015 | 43 | 2015 |
Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation S Servais, Y Beguin, L Delens, G Ehx, G Fransolet, M Hannon, E Willems, ... Expert Opinion on Investigational Drugs 25 (8), 957-972, 2016 | 35 | 2016 |
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease G Fransolet, G Ehx, J Somja, L Delens, M Hannon, J Muller, S Dubois, ... Journal of hematology & oncology 9, 1-12, 2016 | 27 | 2016 |
Major multilevel molecular divergence between THP‐1 cells from different biorepositories N Noronha, G Ehx, MC Meunier, JP Laverdure, C Thériault, C Perreault International Journal of Cancer 147 (7), 2000-2006, 2020 | 24 | 2020 |
In vitro Th17-polarized human CD4+ T cells exacerbate xenogeneic graft-versus-host disease L Delens, G Ehx, J Somja, L Vrancken, L Belle, L Seidel, C Grégoire, ... Biology of Blood and Marrow Transplantation 25 (2), 204-215, 2019 | 24 | 2019 |
The Prosurvival IKK-Related Kinase IKKϵ Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine SI Göktuna, K Shostak, TL Chau, LC Heukamp, B Hennuy, HQ Duong, ... Cancer Research 76 (9), 2587-2599, 2016 | 24 | 2016 |
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients L Canti, KK Ariën, I Desombere, S Humblet-Baron, P Pannus, ... Cancer Cell 40 (4), 335-337, 2022 | 21 | 2022 |
Itacitinib prevents xenogeneic GVHD in humanized mice J Courtois, C Ritacco, S Dubois, L Canti, B Vandenhove, L Seidel, ... Bone Marrow Transplantation 56 (11), 2672-2681, 2021 | 20 | 2021 |
Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets G Ehx, M Hannon, Y Beguin, S Humblet-Baron, F Baron Oncotarget 6 (41), 43255, 2015 | 18 | 2015 |
Spontaneous atopic dermatitis due to immune dysregulation in mice lacking Adamts2 and 14 L Dupont, G Ehx, M Chantry, C Monseur, C Leduc, L Janssen, D Cataldo, ... Matrix Biology 70, 140-157, 2018 | 17 | 2018 |
Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis G Ehx, C Ritacco, M Hannon, S Dubois, L Delens, E Willems, S Servais, ... American Journal of Transplantation 21 (8), 2662-2674, 2021 | 13 | 2021 |
Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancers A Apavaloaei, L Hesnard, MP Hardy, B Benabdallah, G Ehx, C Theriault, ... Cell Reports 40 (7), 2022 | 11 | 2022 |